Meng Ying, Lee Matthew D, Berger Assaf, Wiggins Roy, O'Callaghan James, Bernstein Kenneth, Santhumayor Brandon, Block Kai Tobias, Fatterpekar Girish, Kondziolka Douglas
Department of Neurosurgery, NYU Grossman School of Medicine, New York , New York , USA.
Department of Radiology, NYU Grossman School of Medicine, New York , New York , USA.
Neurosurgery. 2024 Dec 3;97(1):157-165. doi: 10.1227/neu.0000000000003288.
Vestibular schwannomas demonstrate different responses after stereotactic radiosurgery (SRS), commonly including a transient loss of internal enhancement on postcontrast T1-weighted MRI thought to be due to an early reduction in tumor vascularity. We used dynamic contrast-enhanced based golden-angle radial sparse parallel (GRASP) MRI to characterize the vascular permeability changes underlying this phenomenon, with correlations to long-term tumor regression.
Consecutive patients with vestibular schwannoma who underwent SRS between 2017 and 2019, had a transient loss of enhancement after SRS, and had long-term longitudinal GRASP studies (6, 18, and 30 months) were included in this retrospective cohort analysis (n = 19). Using GRAVIS ( https://gravis-imaging.org/gravis/ ), an analysis pipeline for GRASP studies, we extracted the key parameters normalized to the venous sinus from a region of interest within the tumor.
The peak, area under the curve (AUC), and wash-in phase slope were significantly reduced at 6, 18, and 30 months after SRS (corrected P < .05), even while the internal enhancement returned in the tumors. Larger pre-SRS tumors were more likely to have a greater reduction in peak ( P = .013) and AUC ( P = .029) at 6 months. In a subset of patients (N = 13) with long-term follow-up, the median percentage reduction in tumor volume was 58% at a median of 62 months. These patients showed a strong correlation between peak, AUC, and wash-in phase slope changes at 6 months and tumor volume at the last follow-up.
After SRS and loss of internal contrast uptake within vestibular schwannomas, a slow vascular permeability dynamic persisted, suggesting the presence of postradiation processes such as fibrosis. We show for the first time, using GRASP, a quantitative assessment of the vascular radiobiological effect.
前庭神经鞘瘤在立体定向放射外科治疗(SRS)后表现出不同的反应,通常包括在增强后T1加权磁共振成像(MRI)上内部强化的短暂丧失,这被认为是由于肿瘤血管形成的早期减少所致。我们使用基于动态对比增强的金角径向稀疏并行(GRASP)MRI来表征这种现象背后的血管通透性变化,并与长期肿瘤消退相关联。
对2017年至2019年间接受SRS治疗、SRS后出现强化短暂丧失且进行了长期纵向GRASP研究(6个月、18个月和30个月)的连续性前庭神经鞘瘤患者进行了这项回顾性队列分析(n = 19)。使用GRAVIS(https://gravis-imaging.org/gravis/),一种用于GRASP研究的分析流程,我们从肿瘤内的感兴趣区域提取了相对于静脉窦归一化的关键参数。
SRS后6个月、18个月和30个月时,峰值、曲线下面积(AUC)和流入相斜率显著降低(校正P <.05),即使肿瘤内的内部强化恢复。SRS前较大的肿瘤在6个月时更有可能出现峰值(P =.013)和AUC(P =.029)的更大降低。在一组进行长期随访的患者(N = 13)中,在中位62个月时肿瘤体积的中位减少百分比为58%。这些患者在6个月时的峰值、AUC和流入相斜率变化与最后一次随访时的肿瘤体积之间显示出强烈的相关性。
在SRS以及前庭神经鞘瘤内部对比剂摄取丧失后,血管通透性动态变化缓慢持续,提示存在如纤维化等放射后过程。我们首次使用GRASP展示了对血管放射生物学效应的定量评估。